Cargando…

Cognitive Behavioural Therapy and Light Dark Therapy for Maternal Postpartum Insomnia Symptoms: Protocol of a Parallel-Group Randomised Controlled Efficacy Trial

Background: Symptoms of insomnia are common in new mothers and have been associated with a range of negative maternal and child outcomes. Despite this, interventions to improve maternal postpartum sleep remain scarce. Cognitive Behavioural Therapy (CBT) and Light Dark Therapy (LDT) represent two pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Sumedha, Rajaratnam, Shantha M. W., Davey, Margot, Wiley, Joshua F., Bei, Bei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593939/
https://www.ncbi.nlm.nih.gov/pubmed/34816165
http://dx.doi.org/10.3389/fgwh.2020.591677
_version_ 1784599861473050624
author Verma, Sumedha
Rajaratnam, Shantha M. W.
Davey, Margot
Wiley, Joshua F.
Bei, Bei
author_facet Verma, Sumedha
Rajaratnam, Shantha M. W.
Davey, Margot
Wiley, Joshua F.
Bei, Bei
author_sort Verma, Sumedha
collection PubMed
description Background: Symptoms of insomnia are common in new mothers and have been associated with a range of negative maternal and child outcomes. Despite this, interventions to improve maternal postpartum sleep remain scarce. Cognitive Behavioural Therapy (CBT) and Light Dark Therapy (LDT) represent two promising interventions for insomnia symptoms and associated daytime consequences such as fatigue. This randomised controlled trial examines whether CBT and LDT improve maternal insomnia symptoms as the primary outcome and maternal sleep disturbance, mood, fatigue, and sleepiness as secondary outcomes. This protocol paper outlines the development, design, and implementation of the trial. Methods: Participants are an Australian community-sample of 90 first-time mothers who are 4–12 months postpartum with self-reported symptoms of insomnia (Insomnia Severity Index scores ≥ 8). Exclusion criteria include current severe sleep/psychiatric disorders, unsettled infant sleep behaviour, sleep-affecting medication use, and photosensitivity. Eligible women are randomised into a CBT (strategies targeting sleep, worries, fatigue, and relaxation), LDT, or a treatment-as-usual control condition. Interventions are therapist-assisted and personalised through two telephone calls and include a series of automated intervention emails delivered over 6 weeks. Primary and secondary outcomes are assessed at four time points: baseline, intervention mid-point, post-intervention, and 1-month post-intervention. Discussion: If found effective, these interventions could represent efficacious, safe, and inexpensive treatments for improving postpartum insomnia and mitigate its negative impact on maternal well-being. Interventions tested are highly scalable and can be integrated into postpartum care and made available to the broader community. ANZCTR trial registration: Accessible at: https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12618000842268.
format Online
Article
Text
id pubmed-8593939
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85939392021-11-22 Cognitive Behavioural Therapy and Light Dark Therapy for Maternal Postpartum Insomnia Symptoms: Protocol of a Parallel-Group Randomised Controlled Efficacy Trial Verma, Sumedha Rajaratnam, Shantha M. W. Davey, Margot Wiley, Joshua F. Bei, Bei Front Glob Womens Health Global Women's Health Background: Symptoms of insomnia are common in new mothers and have been associated with a range of negative maternal and child outcomes. Despite this, interventions to improve maternal postpartum sleep remain scarce. Cognitive Behavioural Therapy (CBT) and Light Dark Therapy (LDT) represent two promising interventions for insomnia symptoms and associated daytime consequences such as fatigue. This randomised controlled trial examines whether CBT and LDT improve maternal insomnia symptoms as the primary outcome and maternal sleep disturbance, mood, fatigue, and sleepiness as secondary outcomes. This protocol paper outlines the development, design, and implementation of the trial. Methods: Participants are an Australian community-sample of 90 first-time mothers who are 4–12 months postpartum with self-reported symptoms of insomnia (Insomnia Severity Index scores ≥ 8). Exclusion criteria include current severe sleep/psychiatric disorders, unsettled infant sleep behaviour, sleep-affecting medication use, and photosensitivity. Eligible women are randomised into a CBT (strategies targeting sleep, worries, fatigue, and relaxation), LDT, or a treatment-as-usual control condition. Interventions are therapist-assisted and personalised through two telephone calls and include a series of automated intervention emails delivered over 6 weeks. Primary and secondary outcomes are assessed at four time points: baseline, intervention mid-point, post-intervention, and 1-month post-intervention. Discussion: If found effective, these interventions could represent efficacious, safe, and inexpensive treatments for improving postpartum insomnia and mitigate its negative impact on maternal well-being. Interventions tested are highly scalable and can be integrated into postpartum care and made available to the broader community. ANZCTR trial registration: Accessible at: https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12618000842268. Frontiers Media S.A. 2021-01-15 /pmc/articles/PMC8593939/ /pubmed/34816165 http://dx.doi.org/10.3389/fgwh.2020.591677 Text en Copyright © 2021 Verma, Rajaratnam, Davey, Wiley and Bei. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Global Women's Health
Verma, Sumedha
Rajaratnam, Shantha M. W.
Davey, Margot
Wiley, Joshua F.
Bei, Bei
Cognitive Behavioural Therapy and Light Dark Therapy for Maternal Postpartum Insomnia Symptoms: Protocol of a Parallel-Group Randomised Controlled Efficacy Trial
title Cognitive Behavioural Therapy and Light Dark Therapy for Maternal Postpartum Insomnia Symptoms: Protocol of a Parallel-Group Randomised Controlled Efficacy Trial
title_full Cognitive Behavioural Therapy and Light Dark Therapy for Maternal Postpartum Insomnia Symptoms: Protocol of a Parallel-Group Randomised Controlled Efficacy Trial
title_fullStr Cognitive Behavioural Therapy and Light Dark Therapy for Maternal Postpartum Insomnia Symptoms: Protocol of a Parallel-Group Randomised Controlled Efficacy Trial
title_full_unstemmed Cognitive Behavioural Therapy and Light Dark Therapy for Maternal Postpartum Insomnia Symptoms: Protocol of a Parallel-Group Randomised Controlled Efficacy Trial
title_short Cognitive Behavioural Therapy and Light Dark Therapy for Maternal Postpartum Insomnia Symptoms: Protocol of a Parallel-Group Randomised Controlled Efficacy Trial
title_sort cognitive behavioural therapy and light dark therapy for maternal postpartum insomnia symptoms: protocol of a parallel-group randomised controlled efficacy trial
topic Global Women's Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593939/
https://www.ncbi.nlm.nih.gov/pubmed/34816165
http://dx.doi.org/10.3389/fgwh.2020.591677
work_keys_str_mv AT vermasumedha cognitivebehaviouraltherapyandlightdarktherapyformaternalpostpartuminsomniasymptomsprotocolofaparallelgrouprandomisedcontrolledefficacytrial
AT rajaratnamshanthamw cognitivebehaviouraltherapyandlightdarktherapyformaternalpostpartuminsomniasymptomsprotocolofaparallelgrouprandomisedcontrolledefficacytrial
AT daveymargot cognitivebehaviouraltherapyandlightdarktherapyformaternalpostpartuminsomniasymptomsprotocolofaparallelgrouprandomisedcontrolledefficacytrial
AT wileyjoshuaf cognitivebehaviouraltherapyandlightdarktherapyformaternalpostpartuminsomniasymptomsprotocolofaparallelgrouprandomisedcontrolledefficacytrial
AT beibei cognitivebehaviouraltherapyandlightdarktherapyformaternalpostpartuminsomniasymptomsprotocolofaparallelgrouprandomisedcontrolledefficacytrial